Literature DB >> 12459053

Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.

Tracey A Lodie1, Courtney E Blickarz, Tara J Devarakonda, Chufa He, Ajeeta B Dash, Jennifer Clarke, Kristen Gleneck, Lamya Shihabuddin, Ross Tubo.   

Abstract

Adult human bone marrow-derived stem cells, having the ability to differentiate into cells of multiple lineages, have been isolated and propagated by varied protocols, including positive (CD105(+))/negative (CD45(-)GlyA(-)) selection with immunomagnetic beads, or direct plating into selective culture media. Each substratum-adherent cell population was subjected to a systematic analysis of their cell surface markers and differentiation potential. In the initial stages of culture, each cell population proliferated slowly, reaching confluence in 10-14 days. Adherent cells proliferated at similar rates whether cultured in serum-free medium supplemented with basic fibroblast growth factor, medium containing 2% fetal bovine serum (FBS) supplemented with epidermal growth factor and platelet-derived growth factor, or medium containing 10% FBS alone. Cell surface marker analysis revealed that more than 95% of the cells were positive for CD105/endoglin, a putative mesenchymal stem cell marker, and negative for CD34, CD31, and CD133, markers of hematopoietic, endothelial, and neural stem cells, respectively, regardless of cell isolation and propagation method. CD44 expression was variable, apparently dependent on serum concentration. Functional similarity of the stem cell populations was also observed, with each different cell population expressing the cell type-specific markers beta-tubulin, type II collagen, and desmin, and demonstrating endothelial tube formation when cultured under conditions favoring neural, cartilage, muscle, and endothelial cell differentiation, respectively. On the basis of these data, adult human bone marrow-derived stem cells cultured in adherent monolayer are virtually indistinguishable, both physically and functionally, regardless of the method of isolation or proliferative expansion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459053     DOI: 10.1089/10763270260424105

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  18 in total

Review 1.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

2.  [Reaming debris: a source of vital cells! First results of human specimens].

Authors:  K Trinkaus; S Wenisch; C Siemers; D Hose; R Schnettler
Journal:  Unfallchirurg       Date:  2005-08       Impact factor: 1.000

3.  Bone marrow stem cells for urologic tissue engineering.

Authors:  Dave Shukla; Geoffrey N Box; Robert A Edwards; Darren R Tyson
Journal:  World J Urol       Date:  2008-07-25       Impact factor: 4.226

4.  Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.

Authors:  Markus Thomas Rojewski; Barbara Maria Weber; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 5.  Key transcription factors in the differentiation of mesenchymal stem cells.

Authors:  Sami G Almalki; Devendra K Agrawal
Journal:  Differentiation       Date:  2016-03-21       Impact factor: 3.880

6.  Development of methods for studying the differentiation of human mesenchymal stem cells under cyclic compressive strain.

Authors:  Efstathios Michalopoulos; Richard L Knight; Sotirios Korossis; John N Kearney; John Fisher; Eileen Ingham
Journal:  Tissue Eng Part C Methods       Date:  2011-12-13       Impact factor: 3.056

7.  Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.

Authors:  Patrick P Lin; Yongxing Wang; Guillermina Lozano
Journal:  Sarcoma       Date:  2010-10-05

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofluorescence.

Authors:  Matthias Schieker; Christoph Pautke; Florian Haasters; Jana Schieker; Denitsa Docheva; Wolfgang Böcker; Huelya Guelkan; Peter Neth; Marianne Jochum; Wolf Mutschler
Journal:  J Anat       Date:  2007-05       Impact factor: 2.610

10.  Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model.

Authors:  Hao Wu; Di Wen; Ram I Mahato
Journal:  Mol Ther       Date:  2013-06-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.